SCHEMBL4604564

SCHEMBL4604564

NC(=O)COc1c(C(=O)c2ccccc2)sc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP2 Q9HC62 5/20 0.59
SENP1 Q9P0U3 5/20 0.59
SENP5 Q96HI0 4/20 0.59
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
KDM4E B2RXH2 1/20 0.50
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
GABRA1 P14867 1/20 0.46
GABRA5 P31644 1/20 0.46
MAOB P27338 4/20 0.45
IKBKB O14920 1/20 0.43
LIMK1 P53667 1/20 0.43
CXCR2 P25025 1/20 0.43
OGG1 O15527 1/20 0.43
HSD17B10 Q99714 1/20 0.42
MAOA P21397 1/20 0.41
MCL1 Q07820 1/20 0.40
NOD2 Q9HC29 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4603458 0.89 PTPN1 (0.59) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4603300 0.88 PTPN2 (0.51) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL8618124 0.83 ALDH1A1 (0.59) SENP2SENP1SENP5KMT2AALDH1A1
SCHEMBL4605385 0.83 CXCR2 (0.48) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4604537 0.82 SENP2 (0.60) SENP2SENP1SENP5KDM4EALDH1A1
SCHEMBL4605718 0.82 PTPN1 (0.46) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4603123 0.81 GABRA1 (0.56) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4603697 0.81 SENP5 (0.48) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4603919 0.81 MAOB (0.57) SENP2SENP1SENP5PTPN2PTPN1
SCHEMBL4604994 0.81 PTPN1 (0.53) SENP2SENP1SENP5PTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685122-B1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2008-07-09 EP claimed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US claimed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US claimed
EP-1685122-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GmbH (DE) 2006-08-02 EP claimed
WO-2005054226-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2005-06-16 WO claimed
EP-1685122-B1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2008-07-09 EP disclosed
EP-1685122-B1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2008-07-09 EP disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-7371774-B2 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2008-05-13 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
US-20070066680-A1 Benzofurans and benzothiophenes MERCK PATENT GMBH (DE) 2007-03-22 US disclosed
EP-1685122-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005054226-A1 BENZOFURANS AND BENZOTHIOPHENES MERCK PATENT GMBH (DE) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066680-A1 Benzofurans and benzothiophenes INSR, GPR119, IGF1R SENP2 4103/4885SENP1 3205/4885SENP5 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.